US approves first new Alzheimer’s drug in 20 yearson June 7, 2021 at 4:54 pm
There has been controversy around aducanumab, which targets the cause rather than the symptoms. The first new treatment for Alzheimer’s disease for nearly 20 years has been approved by regulators in the United States, paving the way for its use in the UK. Aducanumab targets